Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher G Morris

Showing results (81-90 of 350) with videos related to

Pageof 35
Sort By:
International Journal of Particle Therapy|July 21, 2021
Long-term Outcomes from Proton Therapy for Sinonasal CancersRoi Dagan, Haruka Uezono, Curtis Bryant, et al.
Cancer|August 28, 2007
A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanomaKenneth R Olivier, Steven E Schild, Christopher G Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 2010
T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapyBhishamjit S Chera, Robert J Amdur, Christopher G Morris, et al.
Head & Neck|June 17, 2003
Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neckWilliam M Mendenhall, Christopher G Morris, Robert J Amdur, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-upStanley L Liauw, John E Sylvester, Christopher G Morris, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2019
Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer DatabaseJames E Bates, Christopher G Morris, Michael T Milano, et al.
International Journal of Radiation Oncology, Biology, Physics|January 20, 2007
Long-term outcome after radiotherapy for FIGO stage IIIB and IVA carcinoma of the cervixAnamaria R Yeung, Robert J Amdur, Christopher G Morris, et al.
American Journal of Clinical Oncology|December 7, 2006
Definitive radiotherapy for nasopharyngeal carcinomaWilliam M Mendenhall, Christopher G Morris, Russell W Hinerman, et al.
Acta Oncologica (Stockholm, Sweden)|August 9, 2020
Visual decline in pediatric survivors of brain tumors following radiotherapyJames E Bates, Daniel J Indelicato, Christopher G Morris, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 11, 2022
Adjuvant I-131 therapy for T0-3 N1b M0 differentiated thyroid cancer with many (≥ 5) positive nodesE Charles Fortune, Catherine E Mercado, Peter A Drew, et al.
Pageof 35

Showing results (81-90 of 350) with videos related to

Sort By:
Pageof 35
International Journal of Particle Therapy|July 21, 2021
Long-term Outcomes from Proton Therapy for Sinonasal CancersRoi Dagan, Haruka Uezono, Curtis Bryant, et al.
Cancer|August 28, 2007
A higher radiotherapy dose is associated with more durable palliation and longer survival in patients with metastatic melanomaKenneth R Olivier, Steven E Schild, Christopher G Morris, et al.
International Journal of Radiation Oncology, Biology, Physics|February 16, 2010
T1N0 to T2N0 squamous cell carcinoma of the glottic larynx treated with definitive radiotherapyBhishamjit S Chera, Robert J Amdur, Christopher G Morris, et al.
Head & Neck|June 17, 2003
Parameters that predict local control after definitive radiotherapy for squamous cell carcinoma of the head and neckWilliam M Mendenhall, Christopher G Morris, Robert J Amdur, et al.
International Journal of Radiation Oncology, Biology, Physics|August 5, 2006
Second malignancies after prostate brachytherapy: incidence of bladder and colorectal cancers in patients with 15 years of potential follow-upStanley L Liauw, John E Sylvester, Christopher G Morris, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|June 29, 2019
Immunotherapy with hypofractionated radiotherapy in metastatic non-small cell lung cancer: An analysis of the National Cancer DatabaseJames E Bates, Christopher G Morris, Michael T Milano, et al.
International Journal of Radiation Oncology, Biology, Physics|January 20, 2007
Long-term outcome after radiotherapy for FIGO stage IIIB and IVA carcinoma of the cervixAnamaria R Yeung, Robert J Amdur, Christopher G Morris, et al.
American Journal of Clinical Oncology|December 7, 2006
Definitive radiotherapy for nasopharyngeal carcinomaWilliam M Mendenhall, Christopher G Morris, Russell W Hinerman, et al.
Acta Oncologica (Stockholm, Sweden)|August 9, 2020
Visual decline in pediatric survivors of brain tumors following radiotherapyJames E Bates, Daniel J Indelicato, Christopher G Morris, et al.
Reports of Practical Oncology and Radiotherapy : Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology|April 11, 2022
Adjuvant I-131 therapy for T0-3 N1b M0 differentiated thyroid cancer with many (≥ 5) positive nodesE Charles Fortune, Catherine E Mercado, Peter A Drew, et al.
Pageof 35